1. Home
  2. GLUE vs XPOF Comparison

GLUE vs XPOF Comparison

Compare GLUE & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLUE
  • XPOF
  • Stock Information
  • Founded
  • GLUE 2019
  • XPOF 2017
  • Country
  • GLUE United States
  • XPOF United States
  • Employees
  • GLUE N/A
  • XPOF N/A
  • Industry
  • GLUE Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • GLUE Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • GLUE Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • GLUE 351.2M
  • XPOF 302.9M
  • IPO Year
  • GLUE 2021
  • XPOF 2021
  • Fundamental
  • Price
  • GLUE $4.82
  • XPOF $8.81
  • Analyst Decision
  • GLUE Buy
  • XPOF Buy
  • Analyst Count
  • GLUE 2
  • XPOF 7
  • Target Price
  • GLUE $13.50
  • XPOF $12.93
  • AVG Volume (30 Days)
  • GLUE 423.8K
  • XPOF 986.5K
  • Earning Date
  • GLUE 08-07-2025
  • XPOF 08-07-2025
  • Dividend Yield
  • GLUE N/A
  • XPOF N/A
  • EPS Growth
  • GLUE N/A
  • XPOF N/A
  • EPS
  • GLUE 0.29
  • XPOF N/A
  • Revenue
  • GLUE $177,986,000.00
  • XPOF $316,841,000.00
  • Revenue This Year
  • GLUE $49.02
  • XPOF N/A
  • Revenue Next Year
  • GLUE N/A
  • XPOF $3.45
  • P/E Ratio
  • GLUE $16.38
  • XPOF N/A
  • Revenue Growth
  • GLUE 2990.57
  • XPOF N/A
  • 52 Week Low
  • GLUE $3.50
  • XPOF $6.64
  • 52 Week High
  • GLUE $12.40
  • XPOF $18.87
  • Technical
  • Relative Strength Index (RSI)
  • GLUE 51.76
  • XPOF 45.50
  • Support Level
  • GLUE $4.30
  • XPOF $8.53
  • Resistance Level
  • GLUE $4.70
  • XPOF $9.39
  • Average True Range (ATR)
  • GLUE 0.25
  • XPOF 0.58
  • MACD
  • GLUE 0.02
  • XPOF -0.03
  • Stochastic Oscillator
  • GLUE 85.89
  • XPOF 49.33

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: